Filing Details
- Accession Number:
- 0000937556-17-000058
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-10 17:33:57
- Reporting Period:
- 2017-03-08
- Filing Date:
- 2017-03-10
- Accepted Time:
- 2017-03-10 17:33:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 937556 | Masimo Corp | MASI | Electromedical & Electrotherapeutic Apparatus (3845) | 330368882 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1433095 | Paul Jansen | C/O Masimo Corporation 52 Discovery Irvine CA 92618 | Evp, Bus Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-03-08 | 3,611 | $25.46 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-08 | 3,611 | $94.33 | 6,389 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-03-08 | 10,000 | $30.06 | 16,389 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-08 | 10,000 | $94.33 | 6,389 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-03-08 | 10,000 | $30.06 | 16,389 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-08 | 10,000 | $94.33 | 6,389 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-03-08 | 20,000 | $20.19 | 26,389 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-08 | 20,000 | $94.34 | 6,389 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-03-10 | 12,000 | $19.90 | 18,389 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-03-10 | 12,000 | $94.98 | 6,389 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2017-03-08 | 3,611 | $25.46 | 3,611 | $25.46 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2017-03-08 | 10,000 | $30.06 | 10,000 | $30.06 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2017-03-08 | 10,000 | $30.06 | 10,000 | $30.06 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2017-03-08 | 20,000 | $20.19 | 20,000 | $20.19 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2017-03-10 | 12,000 | $19.90 | 12,000 | $19.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-04-17 | 2018-04-17 | No | 4 | M | Direct |
| 10,000 | 2012-02-22 | 2021-02-22 | No | 4 | M | Direct |
| 0 | 2012-02-22 | 2021-02-22 | No | 4 | M | Direct |
| 0 | 2012-10-27 | 2021-10-27 | No | 4 | M | Direct |
| 8,000 | 2014-03-15 | 2023-03-15 | No | 4 | M | Direct |
Footnotes
- The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of February 22, 2017, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
- The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $94.12 per share to a high of $94.62 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $94.06 per share to a high of $94.69 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $94.03 per share to a high of $94.69 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on April 17, 2008 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
- This option was granted on February 22, 2011 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
- This option was granted on October 27, 2011 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
- This option was granted on March 15, 2013 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
Billionaire Hedge Funds
